Patent application number | Description | Published |
20110028505 | COMPOSITIONS AND METHODS FOR REDUCING FOOD CRAVINGS - Disclosed are compositions for reducing food cravings, comprising a first compound and a second compound, where the first compound is an opioid antagonist and the second compound is an α-MSH agonist. Also disclosed are methods of reducing food cravings, comprising identifying an individual in need thereof and treating that individual to antagonize opioid receptor activity and to enhance α-MSH activity. | 02-03-2011 |
20130177602 | LAYERED PHARMACEUTICAL FORMULATIONS - In one embodiment a layered pharmaceutical formulation includes two or more pharmaceutical layers and an intermediate layer disposed between at least two of the two or more pharmaceutical layers, the intermediate layer configured to dissolve in vivo to thereby leave the two or more pharmaceutical layers substantially intact. In one embodiment, an active pharmaceutical ingredient in at least one of the pharmaceutical layers is selected from bupropion, zonisamide, naltrexone, topiramate, phentermine, metformin, olanzapine and fluoxetine. | 07-11-2013 |
20140080857 | METHODS FOR PROPHYLATIC APPETITE SUPPRESSION - Pharmaceutical formulations comprise sustained-release zonisamide. Methods of preparing such pharmaceutical formulations involve intermixing zonisamide with a suitable excipient configured to control the dissolution profile of the zonisamide. Methods of treatment involve administering the pharmaceutical formulations to patients in need of such treatment. | 03-20-2014 |
20140309252 | COMPOSITIONS AND METHODS FOR REDUCING FOOD CRAVINGS - Disclosed are compositions for reducing food cravings, comprising a first compound and a second compound, where the first compound is an opioid antagonist and the second compound is an α-MSH agonist. Also disclosed are methods of reducing food cravings, comprising identifying an individual in need thereof and treating that individual to antagonize opioid receptor activity and to enhance α-MSH activity. | 10-16-2014 |
20140322318 | METHODS FOR ADMINISTERING WEIGHT LOSS MEDICATIONS - Methods and systems for administration of pharmaceuticals using a unit dosage package that includes a first unit dosage that has a first drug and a second drug, a second unit dosage that has the first drug and the second drug, where the second unit dosage includes a different amount of the second drug than the first unit dosage and a unit dosage package is configured to hold the first unit dosage and the second unit dosage. In preferred embodiments the methods and systems are used for administration of weight loss medications. | 10-30-2014 |
20140323399 | COMPOSITIONS AND METHODS FOR INCREASING INSULIN SENSITIVITY - Methods and compositions for treating a blood glucose condition involve identifying a suitable subject and administering an effective amount of a composition that contains one or more of an opioid antagonist, an anticonvulsant, and a psychotherapeutic agent. The compositions can include insulin. In some embodiments, such methods and compositions can be used to modulate a blood glucose level. In preferred embodiments, such methods and compositions are useful for increasing a subject's sensitivity to insulin. | 10-30-2014 |
20150080424 | SUSTAINED RELEASE FORMULATION OF NALTREXONE - A sustained-release oral dosage form of naltrexone or a pharmaceutically acceptable salt thereof is provided. The oral dosage form may be administered with another compound. Administration of the oral dosage form may reduce a side effect, which may be a side effect at least partially attributable to a weight-loss treatment. The oral dosage form may be administered to treat a weight-loss condition. | 03-19-2015 |
Patent application number | Description | Published |
20120258994 | Preparation and Use of (+)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane In The Treatment of Conditions Affected by Monoamine Neurotransmitters - The present invention relates to (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane and pharmaceutically acceptable active salts, polymorphs, glycosylated derivatives, metabolites, solvates, hydrates, and/or prodrugs of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane and their use alone or in combination with additional psychotherapeutic compositions in the treatment of conditions affected by monoamine neurotransmitters, including treatment of refractory individuals. | 10-11-2012 |
20130123238 | Use of (+)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane to treat addictive and alcohol-related disorders - The present invention relates to (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane and pharmaceutically acceptable salts thereof, compositions comprising (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane or a pharmaceutically acceptable salt thereof, and methods for treating or preventing an alcohol-related or addictive disorder. The (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane or pharmaceutically acceptable salt thereof is preferably substantially free of its corresponding (−)-enantiomer | 05-16-2013 |
20140039029 | PREPARATION AND USE OF (+)-1-(3,4-DICHLOROPHENYL)-3-AZABICYCLO[3.1.0]HEXANE IN THE TREATMENT OF CONDITIONS AFFECTED BY MONOAMINE NEUROTRANSMITTERS - The present invention relates to (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane and pharmaceutically acceptable active salts, polymorphs, glycosylated derivatives, metabolites, solvates, hydrates, and/or prodrugs of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane and their use alone or in combination with additional psychotherapeutic compositions in the treatment of conditions affected by monoamine neurotransmitters, including treatment of refractory individuals. | 02-06-2014 |
Patent application number | Description | Published |
20100291439 | PASTED ZINC ELECTRODE FOR RECHARGEABLE NICKEL-ZINC BATTERIES - Active material for a negative electrode of a rechargeable zinc alkaline electrochemical cell is made with zinc metal particles coated with tin and/or lead. The zinc particles may be coated by adding lead and tin salts to a slurry containing zinc particles, a thickening agent and water. The remaining zinc electrode constituents such as zinc oxide (ZnO), bismuth oxide (Bi | 11-18-2010 |
20110059343 | HEAT SEALING SEPARATORS FOR NICKEL-ZINC CELLS - Embodiments are described in terms of selective methods of sealing separators and jellyroll electrode assemblies and cells made using such methods. More particularly, methods of selectively heat sealing separators to encapsulate one of two electrodes for nickel-zinc rechargeable cells having jellyroll assemblies are described. Selective heat sealing may be applied to both ends of a jellyroll electrode assembly in order to selectively seal one of two electrodes on each end of the jellyroll. | 03-10-2011 |
20120279056 | HEAT SEALING SEPARATORS FOR NICKEL ZINC CELLS - Embodiments are described in terms of selective methods of sealing separators and jellyroll electrode assemblies and cells made using such methods. More particularly, methods of selectively heat sealing separators to encapsulate one of two electrodes for nickel-zinc rechargeable cells having jellyroll assemblies are described. Selective heat sealing may be applied to both ends of a jellyroll electrode assembly in order to selectively seal one of two electrodes on each end of the jellyroll. | 11-08-2012 |
20140030567 | HEAT SEALING SEPARATORS FOR NICKEL ZINC CELLS - Embodiments are described in terms of selective methods of sealing separators and jellyroll electrode assemblies and cells made using such methods. More particularly, methods of selectively heat sealing separators to encapsulate one of two electrodes for nickel-zinc rechargeable cells having jellyroll assemblies are described. Selective heat sealing may be applied to both ends of a jellyroll electrode assembly in order to selectively seal one of two electrodes on each end of the jellyroll. | 01-30-2014 |
20140157586 | PASTED ZINC ELECTRODE FOR RECHARGEABLE NICKEL-ZINC BATTERIES - Active material for a negative electrode of a rechargeable zinc alkaline electrochemical cell is made with zinc metal particles coated with tin and/or lead. The zinc particles may be coated by adding lead and tin salts to a slurry containing zinc particles, a thickening agent and water. The remaining zinc electrode constituents such as zinc oxide (ZnO), bismuth oxide (Bi | 06-12-2014 |
Patent application number | Description | Published |
20090183145 | TECHNIQUES FOR REDUCING DOWN TIME IN UPDATING APPLICATIONS WITH METADATA - A method and apparatus for reducing down time in updating applications with metadata is provided. The application contains both code and metadata. A copy of the application is made. A software update is installed on the copy of the application. During installation, the original application continues to run and service users, who may modify the metadata of the original application. Periodically, the metadata of the copy of the application is updated to incorporate changes to the metadata of the original application. When the software update is completed, users are prevented from further modifying the metadata of the original application. The metadata of the copy of the application is updated to incorporate the final changes to the metadata of the original application. Users are redirected from the original application to the copy of the application. | 07-16-2009 |
20090259993 | Sandbox Support for Metadata in Running Applications - Techniques for using a sandbox to test changes to the metadata of a metadata-driven application. In one set of embodiments, a mainline and a sandbox are created in a runtime environment of a metadata-driven application. The mainline is configured to include a mainline version of a metadata document of the application. The sandbox is configured to include a sandbox (i.e., test) version of the metadata document. At application runtime, requests to access and/or modify the metadata document are serviced either from the mainline or the sandbox based on a sandbox context of the current user session. Thus, changes to the metadata document may be tested on the sandbox version without affecting the mainline version, and vice versa. In various embodiments, multiple sandboxes may be supported in the runtime environment. In further embodiments, the sandbox version may be merged into the mainline version without bringing the runtime environment offline. | 10-15-2009 |
20090313256 | REUSE OF SHARED METADATA ACROSS APPLICATIONS VIA URL PROTOCOL - Techniques for facilitating the sharing of metadata. In one set of embodiments, a metadata document is referenced by a plurality of software applications as a URL, the URL comprising a protocol component identifying a specialized protocol name and a path component identifying a name and namespace of the metadata document. The specialized protocol name indicates that the metadata document is a shared document stored in a shared metadata repository. When an application in the plurality of software applications needs to access the metadata document, the URL is passed to a URL resolver configured to identify the shared metadata repository based on configuration information associated with the application. The metadata document is then retrieved from the shared metadata repository. Since many existing application framework components and standards are adapted to reference metadata documents as URLs, embodiments of the present invention facilitate metadata reuse with minimal or no code changes to the applications or their underlying framework. | 12-17-2009 |
Patent application number | Description | Published |
20110241887 | Waterproof optically-sensing fiberless-optically-communicating vitality monitoring and alarming system, particularly for swimmers and infants - The vitality of a swimmer, or of a child, is monitored by a periodically-activated micro-powered solar- and battery-powered waterproof microminiaturized (1) optical sensor of heart activity, electrically connected to (2) a microprocessor monitor, for jointly determining when a person's heart activity has stopped. When and if required, the microprocessor causes to be transmitted, through water a blue-green light alarm signal. When this optical alarm signal is received by an optical receiver/alarm in air, the receiver/alarm produces an audio and/or visual alarm that, when sensed by a human, potentially timely permits rescue and resuscitation of the swimmer, or the child. The battery-and-solar-powered monitor that forms the core of the vitality monitoring system is roughly ten times faster and more capable, with but one-tenth the power consumption, than previous real-time biological monitoring systems. | 10-06-2011 |
20140378853 | Universal wearable limb band mounting, powering and providing an antenna for, diverse physiological sensors and monitors - A band, or bracelet, is semi-permanently attachable to, and wearable about, a limb of the human body. The limb band is in the physical form of a familiar, and well-accepted, flexible plastic hospital-type wrist bracelet. As well as providing a physical platform to attach, and to mount, any of a large number of diverse portable electronic physiological, motion and like sensors of the human body and its condition, the limb band houses, and electrically connects, any of (1) a battery that is preferably rechargeable, (2) a solar cell for recharging the battery, (3) an antenna, and/or (4) a universal electronic signal connector (such as a miniature USB connector port). In this manner the limb band economically serves as a universal platform for mounting, supplying power and/or abetting wireless and wired communication to and from, wearable electronic sensors and monitors of humans and animals. | 12-25-2014 |
Patent application number | Description | Published |
20080311176 | Drug Condensation Aerosols And Kits - The present invention provides novel condensation aerosols for the treatment of disease and/or intermittent or acute conditions. These condensation aerosols have little or no pyrolysis degradation products and are characterized by having an MMAD of between 1-3 microns. These aerosols are made by rapidly heating a substrate coated with a thin film of drug having a thickness of between 0.05 and 20 μm, while passing a gas over the film, to form particles of a desirable particle size for inhalation. Kits comprising a drug and a device for producing a condensation aerosol are also provided. The device contained in the kit typically, has an element for heating the drug which is coated as a film on the substrate and contains a therapeutically effective dose of a drug when the drug is administered in aerosol form, and an element allowing the vapor to cool to form an aerosol. Also disclosed, are methods for using these aerosols and kits. | 12-18-2008 |
20100297265 | Optimal compositions and methods for treating oral disease and pain - The present invention generally relates to compositions and methods for oral care. In particular it relates to optimal compositions and methods for treating oral disease and pain where the compositions include cesium and/or rubidium. In a composition aspect, the present invention provides a composition for treating oral disease or oral pain. The composition includes cesium bicarbonate, rubidium bicarbonate, or a mixture of cesium bicarbonate and rubidium bicarbonate at a concentration between 40 mM and 110 mM in an aqueous solution. The composition has a pH between 7.0 and 9.0. | 11-25-2010 |
20110046236 | ALCOHOLIC COMPOSITIONS HAVING A LOWERED RISK OF ACETALDEHYDEMIA - The present invention provides beverages and pharmaceutical compositions containing a deuterated alcohol according to Formula 1, and provides methods for their manufacture and use. | 02-24-2011 |
20110244020 | DRUG CONDENSATION AEROSOLS AND KITS - The present invention provides novel condensation aerosols for the treatment of disease and/or intermittent or acute conditions. These condensation aerosols have little or no pyrolysis degradation products and are characterized by having an MMAD of between 1-3 microns. These aerosols are made by rapidly heating a substrate coated with a thin film of drug having a thickness of between 0.05 and 20 μm, while passing a gas over the film, to form particles of a desirable particle size for inhalation. Kits comprising a drug and a device for producing a condensation aerosol are also provided. The device contained in the kit typically, has an element for heating the drug which is coated as a film on the substrate and contains a therapeutically effective dose of a drug when the drug is administered in aerosol form, and an element allowing the vapor to cool to form an aerosol. Also disclosed, are methods for using these aerosols and kits. | 10-06-2011 |
20120172487 | Artificial bone tissue and related methods - The present invention generally relates to an artificial bone composition, methods of making the composition, and methods of using the artificial bone. In one aspect, the present invention is directed to a composition for inclusion in artificial bone. The composition includes hydroxyapatite and between 0.5 weight percent and 1.5 weight percent of a polymer. The composition has a microstructure substantially similar to a marine carbonate skeleton. | 07-05-2012 |
20120172821 | Therapeutic clothing and related methods - The present invention is related to articles of clothing that can be used to lessen the symptoms of particular diseases and/or skin conditions, designs of the clothing, and methods and tools for commercializing and marketing the clothing. In one aspect, the present invention is directed to an article of clothing. The article of clothing includes at least a first coating. The first coating decreases the wicking or absorbance of water as compared to clothing that does not include the coating. | 07-05-2012 |
20130032139 | Drug Condensation Aerosols And Kits - The present invention provides novel condensation aerosols for the treatment of disease and/or intermittent or acute conditions. These condensation aerosols have little or no pyrolysis degradation products and are characterized by having an MMAD of between 1-3 microns. These aerosols are made by rapidly heating a substrate coated with a thin film of drug having a thickness of between 0.05 and 20 μm, while passing a gas over the film, to form particles of a desirable particle size for inhalation. Kits comprising a drug and a device for producing a condensation aerosol are also provided, wherein the device, has an element for heating the drug which is coated as a film on the substrate and contains a therapeutically effective dose of a drug when the drug is administered in aerosol form, and an element allowing the vapor to cool to form an aerosol. Methods for use are also disclosed. | 02-07-2013 |
20140060525 | Drug Condensation Aerosols And Kits - The present invention provides novel condensation aerosols for the treatment of disease and/or intermittent or acute conditions. These condensation aerosols have little or no pyrolysis degradation products and are characterized by having an MMAD of between 1-3 microns. These aerosols are made by rapidly heating a substrate coated with a thin film of drug having a thickness of between 0.05 and 20 μm, while passing a gas over the film, to form particles of a desirable particle size for inhalation. Kits comprising a drug and a device for producing a condensation aerosol are also provided. The device contained in the kit typically, has an element for heating the drug which is coated as a film on the substrate and contains a therapeutically effective dose of a drug when the drug is administered in aerosol form, and an element allowing the vapor to cool to form an aerosol. Also disclosed, are methods for using these aerosols and kits. | 03-06-2014 |
20140066618 | Method Of Forming An Aerosol For Inhalation Delivery - The present invention relates to the inhalation delivery of aerosols containing small particles. Specifically, it relates to a method of forming an aerosol for use in inhalation therapy. The method involves: (a) heating a substrate coated with a composition comprising a drug to form a vapor, wherein the coated composition is in the form of a film less than 10 μthick; and, (b) allowing the vapor to cool, thereby forming an aerosol, which is used in inhalation therapy. In another aspect, a method of forming an aerosol for use in inhalation therapy is provided, wherein the method comprises: (a) heating a substrate coated with a composition comprising a drug to form a vapor in less than 100 milliseconds, wherein the vapor has a mass greater than 0.1 mg; and, (b) allowing the vapor to cool, thereby forming an aerosol, which is used in inhalation therapy | 03-06-2014 |
20150157635 | Method Of Forming An Aerosol For Inhalation Delivery - The present invention relates to the inhalation delivery of aerosols containing small particles. Specifically, it relates to a method of forming an aerosol for use in inhalation therapy. In a method aspect of the present invention, a method of forming an aerosol for use in inhalation therapy is provided. | 06-11-2015 |
20160137959 | ALCOHOLIC COMPOSITIONS HAVING A LOWERED RISK OF ACETALDEHYDEMIA - The present invention provides beverages and pharmaceutical compositions containing a deuterated alcohol according to Formula 1, and provides methods for their manufacture and use. | 05-19-2016 |
Patent application number | Description | Published |
20110240013 | METHOD OF FORMING AN AEROSOL FOR INHALATION DELIVERY - The present invention relates to the inhalation delivery of aerosols containing small particles. Specifically, it relates to a method of forming an aerosol for use in inhalation therapy. In a method aspect of the present invention, a method of forming an aerosol for use in inhalation therapy is provided. The method involves the following steps: (a) heating a substrate coated with a composition comprising a drug at a rate greater than 1000° C./s, thereby forming a vapor; and, (b) allowing the vapor to cool, thereby forming an aerosol, which is used in inhalation therapy. In another method aspect of the present invention, a method of forming an aerosol for use in inhalation therapy is provided. The method involves the following steps: (a) heating a substrate coated with a composition comprising a drug to form a vapor, wherein the coated composition is in the form of a film less than 10μ thick; and, (b) allowing the vapor to cool, thereby forming an aerosol, which is used in inhalation therapy. In another method aspect of the present invention, a method of forming an aerosol for use in inhalation therapy is provided. The method involves the following steps: (a) heating a substrate coated with a composition comprising a drug to form a vapor in less than 100 milliseconds, wherein the vapor has a mass greater than 0.1 mg; and, (b) allowing the vapor to cool, thereby forming an aerosol, which is used in inhalation therapy. | 10-06-2011 |
20130276779 | METHOD OF FORMING AN AEROSOL FOR INHALATION DELIVERY - The present invention relates to the inhalation delivery of aerosols containing small particles. Specifically, it relates to a method of forming an aerosol for use in inhalation therapy. The method involves: (a) heating a substrate coated with a composition comprising a drug to form a vapor, wherein the coated composition is in the form of a film less than 10μ thick; and, (b) allowing the vapor to cool, thereby forming an aerosol, which is used in inhalation therapy. In another aspect, a method of forming an aerosol for use in inhalation therapy is provided, wherein the method comprises: (a) heating a substrate coated with a composition comprising a drug to form a vapor in less than 100 milliseconds, wherein the vapor has a mass greater than 0.1 mg; and, (b) allowing the vapor to cool, thereby forming an aerosol, which is used in inhalation therapy | 10-24-2013 |
Patent application number | Description | Published |
20140322358 | Compositions and methods for amelioration of chronic renal failure and related symptoms in domestic animals - The present invention is generally directed to compositions and methods for amelioration chronic renal failure and related symptoms in domestic animals. In one case, the present invention is directed to a composition for the treatment of chronic renal failure in a domestic animal or symptoms related to chronic renal failure. The composition comprises a Fruit- and Vegetable-Based Additive. In another case, the present invention is directed to a composition for the treatment of chronic renal failure in a domestic animal or symptoms related to chronic renal failure. The composition comprises a Cesium and/or Rubidium salt. In another case, the present invention is directed to a composition for the treatment of chronic renal failure in a domestic animal or symptoms related to chronic renal failure. The composition comprises a Dehydrated Domestic Animal Food and a Phosphate Binder. | 10-30-2014 |
20150017699 | Internally functionalized graphene substrates - The present invention is generally directed to internally functionalized graphene substrates, methods of making such substrates and methods of using such substrates. In one aspect, the present invention is a graphene substrate. The substrate comprises edge and non-edge regions. Organic or inorganic molecules are bound to the non-edge regions of the substrate, and the organic or inorganic molecules are present on the substrate edges at a population greater than about one molecule per 10,000 nm | 01-15-2015 |
20150313941 | Composition and methods for amelioration of diseases and related symptoms in domestic animals - The present invention is generally directed to compositions and methods for amelioration of diseases and related symptoms in domestic animals. In one aspect, the invention is directed to a method of ameliorating the symptoms of arthritis, brain aging, cataracts, diabetes, dermatitis, FLUTD, glaucoma, low energy levels or obesity in a domestic animal, wherein the method comprises administering a composition to the animal, wherein the composition comprises a Fruit-Based Additive, a Vegetable-Based Additive or a Fruit- and Vegetable-Based Additive. | 11-05-2015 |
20150314005 | Compositions and methods for amelioration of diseases and related symptoms in humans - The present invention is generally directed to compositions and methods for amelioration of diseases and related symptoms in humans. In one aspect, the invention is directed to a method of ameliorating the symptoms of arthritis, brain aging, cataracts, diabetes, dermatitis, chronic renal failure, glaucoma, low energy levels or obesity in a human, wherein the method comprises administering a composition to the animal, wherein the composition comprises a Fruit-Based Additive, a Vegetable-Based Additive or a Fruit- and Vegetable-Based Additive. | 11-05-2015 |
Patent application number | Description | Published |
20080263094 | MULTI-RENDERED MULTIMEDIA SITE GENERATION APPARATUS, SYSTEMS, AND METHODS - Apparatus, systems, and methods disclosed herein may download one or more sets of presentation rendering property values (PRPVs) to a client processing device. Each set of PRPVs may be associated with a set of presentation characteristics of a sensory output device (SOD) used to present a multimedia presentation, a state of the SOD, or a state of a filter used to filter the presentation. A subset of PRPVs may be associated with a presentation element. A presentation page containing the presentation element may be assembled at a multi-rendered presentation server from a template, a set of controls, a view, and a dataset. The page may be assembled such that the set of PRPVs, acting upon the presentation element at the client processing device, is capable of rendering the presentation element for presentation at the SOD with a predetermined set of perceptual characteristics compatible with SOD presentation characteristics. | 10-23-2008 |
20080263432 | CONTEXT DEPENDENT PAGE RENDERING APPARATUS, SYSTEMS, AND METHODS - Apparatus, systems, and methods disclosed herein may receive one or more sets of presentation rendering property values (PRPVs) at a client processing device from a network device. A set of PRPVs may be associated with a set of presentation characteristics of a sensory output device (SOD) used to present a multimedia presentation, a state of the SOD, or a state of a filter used to filter the presentation. A subset of PRPVs may be associated with a presentation element. An operating system or other entity associated with the client processing device may be interrogated to determine a state of the SOD or of the filter. Using the subset of PRPVs, the presentation element may be rendered for presentation at the SOD with a set of predetermined perceptual characteristics compatible with the presentation characteristics associated with the SOD. Other embodiments may be described and claimed. | 10-23-2008 |
20100042734 | PROXY SERVER ACCESS RESTRICTION APPARATUS, SYSTEMS, AND METHODS - Apparatus, systems, and methods disclosed herein disallow connections from one or more remote clients associated with an Internet protocol (IP) address for a period of disallowance if a number of connection requests from the one or more clients associated with the IP address exceeds a threshold number during a threshold time period. Other embodiments are described and claimed. | 02-18-2010 |
Patent application number | Description | Published |
20090013560 | Shoe with writing surface - A shoe is provided with a writing surface so that temporary expressive indicia can be applied to the shoe. The writing surface is preferably in the form of a side surface of the shoe extending between a tread and a foot contacting surface of the shoe. The side surface is preferably formed of patent leather compatible with a dry erase marker provided as a writing implement. In a most preferred form of the invention, the shoe includes a bore which acts as a housing for the marker or other writing implement to conveniently store the writing implement when not in use. The bore or other housing also keeps the writing implement fresh by sealing the writing implement within the bore when not in use, especially when the writing implement is a dry erase marker. | 01-15-2009 |
20090294499 | Bag with writing surface - The bag includes a carrier implement such as straps for a backpack, at least one interior compartment and an outer panel defining a portion of an exterior of the bag. This outer panel is formed of a material which can receive ink in a removably attachable fashion, such that the outer panel can be decorated with a writing implement and decorations can be removed and modified. In one embodiment the outer panel is formed of patent leather with the writing implement in the form of a dry erase marker. A backing panel is provided inboard of the outer panel to add rigidity to the outer panel and facilitate writing thereon. Stitching around a perimeter of the outer panel joins the outer panel to the backing panel, as well as an inner liner to hold the outer panel securely in place. | 12-03-2009 |
20100107441 | Shoe with writing surface - A shoe is provided with a writing surface so that temporary expressive indicia can be applied to the shoe. The writing surface is preferably in the form of a side surface of the shoe extending between a tread and a foot contacting surface of the shoe. The side surface is preferably formed of patent leather compatible with a dry erase marker provided as a writing implement. In a most preferred form of the invention, the shoe includes a bore which acts as a housing for the marker or other writing implement to conveniently store the writing implement when not in use. The bore or other housing also keeps the writing implement fresh by sealing the writing implement within the bore when not in use, especially when the writing implement is a dry erase marker. | 05-06-2010 |
Patent application number | Description | Published |
20110230829 | Arterial Tamponade Device and Method - An arterial tamponade device is expandable between a collapsed condition and a fully expanded position and has opposite ends which are spaced farther apart in the expanded position. A foot or pressure pad is associated with at least one end of the device. The device is inserted into a body cavity in its collapsed state and is released at a predetermined location so that opposite ends of the device are biased away from one another and engage and apply pressure to opposite wall areas of the body cavity before the device is fully expanded, with the pressure pad positioned to apply pressure to a predetermined tissue area which includes a blood vessel so as to occlude or partially occlude the vessel and reduce or cut off blood flow to the body cavity. | 09-22-2011 |
20110230907 | ARTERIAL TAMPONADE DEVICE AND METHOD - An arterial tamponade device is expandable between a collapsed condition and an expanded position and has opposite ends, with an enlarged pad at one or both ends. The device is inserted into a body cavity in its collapsed condition and is released at a predetermined location so that opposite ends of the device are biased away from one another and apply pressure to opposite wall regions of the body cavity before the device is fully expanded, with a pad at one end positioned to apply pressure to a predetermined tissue area which includes a blood vessel so as to occlude or partially occlude the vessel and reduce or cut off blood flow to the body cavity. The pad may have a bulbous projection configured to engage a depression of a body cavity wall region in which a blood vessel is located. | 09-22-2011 |
20130079808 | ARTERIAL TAMPONADE DEVICE - An arterial tamponade device has an elongate connecting member of resiliently deformable material with pressure pads at each end of the member, and is expandable between a generally U-shaped or V-shaped collapsed condition and a fully expanded position. The device is inserted into a body cavity in its collapsed state and is released at a predetermined location so that opposite ends of the device are biased away from one another and the pressure pads engage and apply pressure to opposite wall areas of the body cavity before the device is fully expanded. One pressure pad has a bulbous end portion angled away from the connecting member and designed to engage and apply pressure to a predetermined tissue area which includes one or more blood vessels so as to occlude or partially occlude the vessel or vessels and reduce or cut off blood flow to the body cavity. | 03-28-2013 |
20140074143 | INSERTION TOOL AND INSERTION METHOD FOR ARTERIAL TAMPONADE DEVICE - An ergonomic insertion tool for insertion and retrieval of an arterial tamponade device which has an elongate connecting strut of resiliently deformable material and an arterial compressor at one end. The tool has a handle with a hand grip portion including an actuating trigger, and an elongate barrel. The barrel has a shaft and an outer sleeve telescopically engaged over the shaft. In a first position, a hooked distal end of the shaft protrudes from the sleeve to engage a bend between adjacent end portions of the connecting strut. On movement into a second position, the sleeve extends over the hooked end and compresses the deformable connecting strut into a deformed, U-shaped configuration to hold the device during insertion or retrieval. On movement back into the first position, the deformed device is released to spring out towards the expanded condition. | 03-13-2014 |
20140172014 | CRANIAL BASE IMPLANT DEVICE - A device for closing a hole in a sphenoid bone that acts as a barrier between a sella turcica and a sphenoid sinus is disclosed. The device includes a cap and a stem. The cap is formed of a deformable material. The cap includes a contact surface and an upper surface. The contact surface forms a base of the cap and includes an outer perimeter. The upper surface includes an apex offset from the contact surface. The upper surface extends from the apex to the outer perimeter. The stem extends from the contact surface in a direction opposite the apex. | 06-19-2014 |
20140180411 | RETINAL REPAIR DEVICE AND METHOD - A device which may be formed of suitable elastomeric, biocompatible material is configured to be wedged into Tenon's space between the orbital and scleral walls of the eye at the location of a retinal tear or break. When positioned, the device pushes the eye wall inward to close the tear, and fluid below the retinal wall resorbs. | 06-26-2014 |
Patent application number | Description | Published |
20130191728 | SYSTEMS, METHODS, AND MEDIA FOR GENERATING ELECTRONIC BOOKS - Systems, methods, and media for generating electronic books are provided herein. Methods may include obtaining digital source content, the digital source content being arranged in a native format, the native format determining how the digital source content is displayed on a user interface, and determining characteristics from the digital source content, the characteristics at least defining a layout of the digital source content in the native format; and rendering the determined content into an electronic book according to an electronic book standard, based upon the characteristics such that a generated format of the electronic book substantially corresponds to the native format of the digital source content. | 07-25-2013 |
20130275254 | DIGITAL MEDIA PERSONALIZATION - Systems, methods, and media for digital media personalization are provided herein. Methods may include selecting an upcoming digital media publication to be published over a network, selecting prior to publishing the digital media publication, a portion of the digital media publication that is to be personalized after the digital media publication is published, establishing, prior to publishing the digital media publication, characteristics for personalization of the portion of the digital media publication, and publishing the personalizeable digital media publication over the network. | 10-17-2013 |
20140237333 | Digital Media Personalization - Systems, methods, and media for digital media personalization are provided herein. Methods may include selecting an upcoming digital media publication to be published over a network, selecting prior to publishing the digital media publication, a portion of the digital media publication that is to be personalized after the digital media publication is published, establishing, prior to publishing the digital media publication, characteristics for personalization of the portion of the digital media publication, and publishing the personalizable digital media publication over the network. | 08-21-2014 |
20150033116 | Systems, Methods, and Media for Generating Structured Documents - Systems, methods, and media for generating structured documents are provided herein. Methods may include receiving digital source content, the digital source content having source data elements where each source data element includes one or more attributes, determining the one or more attributes for each of the source data elements, tagging each of the source data elements with an identifier based upon their one or more attributes, the identifier defining a function for a particular source data element with a structured document, and generating a structured document from the tagged source data elements. | 01-29-2015 |
20150228197 | Adaptive Learning Components for Electronic Books - Adaptive learning components for electronic books and publications are provided herein. Methods may include receiving content selections from an end user, the content selections being obtained from content included in the electronic book, including the content selections into a virtual study container, determining descriptive metadata for the content selections in the virtual study container, generating an instructional learning component using the descriptive metadata determined from the content selections. The instructional learning component having instructional information that corresponds to the content selections included in the virtual study container, and displaying the instructional learning component within the electronic book. | 08-13-2015 |
Patent application number | Description | Published |
20110148756 | NAVIGATION AND SELECTION CONTROL FOR A WIRELESS HANDSET - A user input device for a wireless handset and a method for receiving user input on a wireless handset is described. The user input device comprises a trackpad and a selection button. The wireless handset has a display that presents a graphical user interface. The graphical user interface is updated in accordance with input received at the user input device. | 06-23-2011 |
20110216009 | SNAP-ON KEYPAD FOR A WIRELESS HANDSET - A wireless handset having a top housing with integrated keypad and method for navigating a wireless handset interface using the keypad is described. The wireless handset comprises a top housing having a plurality of tabs which mate with slots of a mating housing such that the break line between the top housing and the mating housing occurs on the sidewall of the wireless handset. | 09-08-2011 |
20110227810 | PORTABLE COMMUNICATION DEVICE WITH SECONDARY PERIPHERAL DISPLAY - A portable communication device includes a primary display and a secondary display where the secondary display surrounds the primary display. The secondary display is translucent allowing at least some light to pass through the display to form a clear, or nearly clear, bezel around the primary display. A dot matrix system or clear LCD generates images on the secondary display and a sensing mechanism, such as a set of capacitor sensors, detects user input. User interaction with objects presented on the secondary display allows the user to manage content in the primary display. | 09-22-2011 |
20110241998 | FLEXIBLE PORTABLE COMMUNICATION DEVICE - A portable communication device includes a housing having at least three housing portions where a first housing portion is rotatably connected to a second housing portion and the second housing portion is rotatably connected to a third housing portion. A flexible display screen is connected to the first, second, and third housing portions to form a continuous surface having a first screen portion connected to the first housing portion, a second screen portion connected to the second housing portion and a third screen portion connected to the third housing portion. The portable communication device is configurable into at least three configurations including an open position where the entire screen surface is exposed and visible to the user and a closed position where the housing portions are folded to each other such that the entire screen surface is unexposed. A partially closed position allows the user to view a portion of the display screen. | 10-06-2011 |